Leslie Lewis Dan
Gründer bei Novopharm Ltd.
Profil
Leslie Lewis Dan is the founder of Novopharm Ltd.
(1964) and Viventia Bio, Inc. (2012), where he holds the title of Chairman.
He was also the Chairman of Viventia Biotech, Inc. and a Director at Teva Pharmaceutical Industries Ltd.
(2001-2007), Deprenyl Research Ltd.
(1993-2008), Sesen Bio, Inc. (2016-2019), and Jubilant DraxImage, Inc. (1993-2003).
Mr. Dan received his undergraduate degree in 1954 and his MBA in 1959, both from the University of Toronto.
Aktive Positionen von Leslie Lewis Dan
Unternehmen | Position | Beginn |
---|---|---|
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Novopharm Ltd. is a Canadian company that develops pharmaceutical products. The company is based in Toronto, Canada. Novopharm was acquired by Teva Pharmaceutical Industries Ltd. on February 01, 2000. The company was founded by Leslie Lewis Dan. | Gründer | 01.01.1964 |
Ehemalige bekannte Positionen von Leslie Lewis Dan
Unternehmen | Position | Ende |
---|---|---|
CARISMA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.07.2019 |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Vorstandsvorsitzender | 01.01.2015 |
Deprenyl Research Ltd.
Deprenyl Research Ltd. Pharmaceuticals: MajorHealth Technology Deprenyl Research Ltd. manufactures, develops, produces and distributes diagnostic and therapeutic products. The company was headquartered in Kirkland, Canada. | Direktor/Vorstandsmitglied | 28.05.2008 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Direktor/Vorstandsmitglied | 01.01.2007 |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Direktor/Vorstandsmitglied | 01.01.2003 |
Ausbildung von Leslie Lewis Dan
University of Toronto | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Private Unternehmen | 6 |
---|---|
Deprenyl Research Ltd.
Deprenyl Research Ltd. Pharmaceuticals: MajorHealth Technology Deprenyl Research Ltd. manufactures, develops, produces and distributes diagnostic and therapeutic products. The company was headquartered in Kirkland, Canada. | Health Technology |
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Novopharm Ltd. is a Canadian company that develops pharmaceutical products. The company is based in Toronto, Canada. Novopharm was acquired by Teva Pharmaceutical Industries Ltd. on February 01, 2000. The company was founded by Leslie Lewis Dan. | Health Technology |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Jubilant Draximage, Inc.
Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada. | Health Technology |